Laboratorios Richmond seeks partial debt delisting after repurchasing ARS 9.45 billion and USD 1.74 million notes

• Laboratorios Richmond requested a partial delisting tied to the cancellation of its Obligaciones Negociables Serie VII Clase A.
• Listed amount to drop to V/N $ 1.68 billion from V/N $ 11.12 billion.
• Obligaciones Negociables Serie VII Clase B listed amount to fall to V/N U$S 760,750 from V/N U$S 2.5 million.
• Action reflects cancellation of treasury-held notes received via in-kind subscription for Serie VIII Clase A and Clase B issued July 31, 2026.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Laboratorios Richmond SACIF published the original content used to generate this news brief on August 24, 2026, and is solely responsible for the information contained therein.